{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:28:15Z","timestamp":1787243295228,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04450-z","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:14:15Z","timestamp":1781309655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intestinal SMARCA4-deficient undifferentiated carcinoma: a case series and systematic review of the literature"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenjing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenda","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongta","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"4450_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA, Board WHOCTE. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182\u20138.","journal-title":"Histopathology"},{"key":"4450_CR2","doi-asserted-by":"crossref","unstructured":"Armon S, Hofman P, Ilie M. Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients. Cells. 2021;10: 1920.","DOI":"10.3390\/cells10081920"},{"key":"4450_CR3","doi-asserted-by":"publisher","first-page":"100183","DOI":"10.1016\/j.modpat.2023.100183","volume":"36","author":"AJ Neil","year":"2023","unstructured":"Neil AJ, Zhao L, Isidro RA, Srivastava A, Cleary JM, Dong F. SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach. Mod Pathol. 2023;36:100183.","journal-title":"Mod Pathol"},{"key":"4450_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.32074\/1591-951X-1272","volume":"117","author":"S Das","year":"2025","unstructured":"Das S, Mishra P, Ahlawat S. Clinicopathological and molecular perspectives on thoracic SMARCA4-deficient undifferentiated tumors and SMARCA4-deficient non-small cell lung carcinomas. Pathologica. 2025;117:455\u201367.","journal-title":"Pathologica"},{"key":"4450_CR5","doi-asserted-by":"publisher","first-page":"154706","DOI":"10.1016\/j.phymed.2023.154706","volume":"112","author":"Y Yang","year":"2023","unstructured":"Yang Y, Xu Y, Qian S, Tang T, Wang K, Feng J, Ding R, Yao J, Huang J, Wang J. Systematic investigation of the multi-scale mechanisms of herbal medicine on treating ventricular remodeling: Theoretical and experimental studies. Phytomedicine. 2023;112:154706.","journal-title":"Phytomedicine"},{"key":"4450_CR6","first-page":"868","volume":"51","author":"PP Zhu","year":"2022","unstructured":"Zhu PP, Li XX, Liu JH, Du XL, Su HY, Wang J. [SMARCA4-deficient undifferentiated carcinoma of the gastrointestinal tract: a clinicopathological and immunohistochemical study of nine cases]. Zhonghua Bing Li Xue Za Zhi. 2022;51:868\u201374.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"4450_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1177\/10668969241291884","volume":"33","author":"Y Zhong","year":"2025","unstructured":"Zhong Y, Liu J, Sun K, Wang G, Li B, Liu Y, Chen N, Chen Z. Gastric SMARCA4-Deficient Undifferentiated Carcinoma: A Report of 4 Patients and Literature Review. Int J Surg Pathol. 2025;33:809\u201319.","journal-title":"Int J Surg Pathol"},{"key":"4450_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","volume":"40","author":"A Agaimy","year":"2016","unstructured":"Agaimy A, Daum O, Markl B, Lichtmannegger I, Michal M, Hartmann A. SWI\/SNF Complex-deficient Undifferentiated\/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2. Am J Surg Pathol. 2016;40:544\u201353.","journal-title":"Am J Surg Pathol"},{"key":"4450_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12328-022-01602-y","volume":"15","author":"Y Meda","year":"2022","unstructured":"Meda Y, Miyake H, Nagai H, Yoshioka Y, Yuasa N, Kiriyama A, Fujino M. SMARCA4-deficient rectal carcinoma with a sarcomatoid component: a case report. Clin J Gastroenterol. 2022;15:419\u201326.","journal-title":"Clin J Gastroenterol"},{"key":"4450_CR10","doi-asserted-by":"publisher","first-page":"665056","DOI":"10.3389\/fonc.2021.665056","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen C, Yin W, Wang X, Li P, Chen Y, Jin X, Yang P, Wu H. Synchronous Malignant Gastrointestinal Neuroectodermal Tumor and SMARCA4-Deficient Undifferentiated Carcinoma With Independent Origins in the Small Intestine: A Case Report. Front Oncol. 2021;11:665056.","journal-title":"Front Oncol"},{"key":"4450_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/PAS.0000000000001836","volume":"46","author":"B Chang","year":"2022","unstructured":"Chang B, Sheng W, Wang L, Zhu X, Tan C, Ni S, Weng W, Huang D, Wang J. SWI\/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies. Am J Surg Pathol. 2022;46:889\u2013906.","journal-title":"Am J Surg Pathol"},{"key":"4450_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s12328-023-01853-3","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin J Gastroenterol. 2023;16:807\u201314.","journal-title":"Clin J Gastroenterol"},{"key":"4450_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.5306\/wjco.v15.i3.456","volume":"15","author":"YN Shi","year":"2024","unstructured":"Shi YN, Zhang XR, Ma WY, Lian J, Liu YF, Li YF, Yang WH. PD-1 antibody in combination with chemotherapy for the treatment of SMARCA4-deficient advanced undifferentiated carcinoma of the duodenum: Two case reports. World J Clin Oncol. 2024;15:456\u201363.","journal-title":"World J Clin Oncol"},{"key":"4450_CR14","first-page":"52","volume":"31","author":"X Cai","year":"2026","unstructured":"Cai X, Liu S, Li L, Zhang Y, Guo Q, Chen Z, Qu M, Wang Y, Yang B, Yue X. Small intestinal SMARCA4-deficient undifferentiated carcinoma with intussusception: A case report. Oncol Lett. 2026;31:52.","journal-title":"Oncol Lett"},{"key":"4450_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13000-021-01091-6","volume":"16","author":"H Duan","year":"2021","unstructured":"Duan H, Gao W, Wang L, Cao F, Teng L. Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review. Diagn Pathol. 2021;16:30.","journal-title":"Diagn Pathol"},{"key":"4450_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/00031348241269413","volume":"91","author":"J Wassef","year":"2025","unstructured":"Wassef J, Kaye P. SMARCA4-Deficient Colonic Tumor in a Patient with mutY DNA Glycosylase (MUTYH) Associated Polyposis. Am Surg. 2025;91:141\u20133.","journal-title":"Am Surg"},{"key":"4450_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.humpath.2017.05.024","volume":"70","author":"S Kuwamoto","year":"2017","unstructured":"Kuwamoto S, Matsushita M, Takeda K, Tanaka N, Endo Y, Yamasaki A, Kohashi K, Oda Y, Horie Y. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources. Hum Pathol. 2017;70:92\u20137.","journal-title":"Hum Pathol"},{"key":"4450_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","volume":"26","author":"E Herpel","year":"2017","unstructured":"Herpel E, Rieker RJ, Dienemann H, Muley T, Meister M, Hartmann A, Warth A, Agaimy A. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol. 2017;26:47\u201351.","journal-title":"Ann Diagn Pathol"},{"key":"4450_CR19","doi-asserted-by":"publisher","first-page":"30897","DOI":"10.1074\/jbc.R111.309302","volume":"287","author":"G Euskirchen","year":"2012","unstructured":"Euskirchen G, Auerbach RK, Snyder M. SWI\/SNF chromatin-remodeling factors: multiscale analyses and diverse functions. J Biol Chem. 2012;287:30897\u2013905.","journal-title":"J Biol Chem"},{"key":"4450_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/PAS.0000000000001599","volume":"45","author":"RK Horton","year":"2021","unstructured":"Horton RK, Ahadi M, Gill AJ, Said S, Chen ZE, Bakhshwin A, Nichols M, Goldblum JR, Graham RP. SMARCA4\/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. Am J Surg Pathol. 2021;45:414\u201320.","journal-title":"Am J Surg Pathol"},{"key":"4450_CR21","doi-asserted-by":"publisher","first-page":"1297140","DOI":"10.3389\/fonc.2024.1297140","volume":"14","author":"Z Lin","year":"2024","unstructured":"Lin Z, Li Q, He Y, Guo S, Ye Y, Liu Z. Case report: Gastric carcinoma with SMARCA4 deficient: two cases report and literature review. Front Oncol. 2024;14:1297140.","journal-title":"Front Oncol"},{"key":"4450_CR22","doi-asserted-by":"publisher","first-page":"151759","DOI":"10.1016\/j.anndiagpath.2021.151759","volume":"53","author":"A Agaimy","year":"2021","unstructured":"Agaimy A, Naroditsky I, Ben-Izhak O. Primary high-grade myoepithelial carcinoma of the lung: A study of three cases illustrating frequent SMARCB1-deficiency and review of the literature. Ann Diagn Pathol. 2021;53:151759.","journal-title":"Ann Diagn Pathol"},{"key":"4450_CR23","doi-asserted-by":"publisher","first-page":"8094","DOI":"10.1158\/0008-5472.CAN-09-0733","volume":"69","author":"X Wang","year":"2009","unstructured":"Wang X, Sansam CG, Thom CS, Metzger D, Evans JA, Nguyen PT, Roberts CW. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI\/SNF chromatin remodeling complex. Cancer Res. 2009;69:8094\u2013101.","journal-title":"Cancer Res"},{"key":"4450_CR24","doi-asserted-by":"crossref","unstructured":"Song Q, Xie J, Guan M, Wu H, Lv Y, Yuan M, Wang Y, Zhao J, Jiang Z, Zhang Y, Pu X. The pan-cancer landscape of SMARCA4 and SMARCB1 alterations in a large cohort of Chinese patients. J Clin Oncol. 2024;42(16).","DOI":"10.1200\/JCO.2024.42.16_suppl.e14636"},{"key":"4450_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jare.2024.10.026","volume":"75","author":"X Wang","year":"2025","unstructured":"Wang X, Yang J, Yang W, Sheng H, Jia B, Cheng P, Xu S, Hong X, Jiang C, Yang Y, et al. Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m(6)A modification and diverse cell death mechanisms. J Adv Res. 2025;75:539\u201360.","journal-title":"J Adv Res"},{"key":"4450_CR26","doi-asserted-by":"crossref","unstructured":"Dong Y, Li M, Zhang Y, Li W, Wang J, Wang Z. Multi-Omics Analysis of SMARCA4-Deficient Tumors. Journal of Thoracic Oncology. 2024;19(10):S333.","DOI":"10.1016\/j.jtho.2024.09.599"},{"key":"4450_CR27","doi-asserted-by":"publisher","first-page":"156809","DOI":"10.1016\/j.phymed.2025.156809","volume":"142","author":"G Gao","year":"2025","unstructured":"Gao G, Zhang X, Wang Z, Xu J, Wang J, Liu T, Xie Z. Multiscale insights into cornuside\u2019s effects on NAFLD: A cross-disciplinary integrating bioinformatics, computational chemistry, and machine learning. Phytomedicine. 2025;142:156809.","journal-title":"Phytomedicine"},{"key":"4450_CR28","doi-asserted-by":"publisher","first-page":"107818","DOI":"10.1016\/j.lungcan.2024.107818","volume":"192","author":"M Shi","year":"2024","unstructured":"Shi M, Pang L, Zhou H, Mo S, Sheng J, Zhang Y, Liu J, Sun D, Gong L, Wang J, et al. Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods. Lung Cancer. 2024;192:107818.","journal-title":"Lung Cancer"},{"key":"4450_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","volume":"404","author":"C Eng","year":"2024","unstructured":"Eng C, Yoshino T, Ruiz-Garcia E, Mostafa N, Cann CG, O\u2019Brian B, Benny A, Perez RO, Cremolini C. Colorectal cancer. Lancet. 2024;404:294\u2013310.","journal-title":"Lancet"},{"key":"4450_CR30","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","volume":"43","author":"R Abedizadeh","year":"2024","unstructured":"Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev. 2024;43:729\u201353.","journal-title":"Cancer Metastasis Rev"},{"key":"4450_CR31","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1080\/14656566.2025.2608867","volume":"26","author":"M Piotrowski","year":"2025","unstructured":"Piotrowski M, Suska K, Jacenik D, Fichna J. Current advances in colorectal cancer treatment: a review of recent clinical trials. Expert Opin Pharmacother. 2025;26:1949\u201359.","journal-title":"Expert Opin Pharmacother"},{"key":"4450_CR32","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065.","journal-title":"Nat Rev Dis Primers"},{"key":"4450_CR33","doi-asserted-by":"crossref","unstructured":"Haynes J, Manogaran P. Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer. Int J Mol Sci. 2025;26(5):1988.","DOI":"10.3390\/ijms26051988"},{"key":"4450_CR34","doi-asserted-by":"publisher","first-page":"151302","DOI":"10.1016\/j.ijbiomac.2026.151302","volume":"354","author":"H Song","year":"2026","unstructured":"Song H, Chen F, Lin S, Gao H, Zhang Z, Ge Y, Ye T, Wang Z, Huo X, Wang J, Liu B. Targeting HSP90 destabilization with ganoderic acid a as a novel therapeutic strategy for hepatoblastoma. Int J Biol Macromol. 2026;354:151302.","journal-title":"Int J Biol Macromol"},{"key":"4450_CR35","doi-asserted-by":"publisher","first-page":"108817","DOI":"10.1016\/j.lungcan.2025.108817","volume":"210","author":"X Wang","year":"2025","unstructured":"Wang X, Shi W, Xiao Y, Wang H, Si H, Kang Y, Si J, Liu Y, Li S, Jin J. The immune desert tumor microenvironment in Thoracic SMARCA4-deficient undifferentiated tumors: spatial distribution characteristics and prognostic significance. Lung Cancer. 2025;210:108817.","journal-title":"Lung Cancer"},{"key":"4450_CR36","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1158\/1078-0432.CCR-18-3778","volume":"25","author":"R Pinyol","year":"2019","unstructured":"Pinyol R, Sia D, Llovet JM. Immune Exclusion-Wnt\/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC. Clin Cancer Res. 2019;25:2021\u20133.","journal-title":"Clin Cancer Res"},{"key":"4450_CR37","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/annonc\/mdz160","volume":"30","author":"C Henon","year":"2019","unstructured":"Henon C, Blay JY, Massard C, Mir O, Bahleda R, Dumont S, Postel-Vinay S, Adam J, Soria JC, Le Cesne A. Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. Ann Oncol. 2019;30:1401\u20133.","journal-title":"Ann Oncol"},{"key":"4450_CR38","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/his.14612","volume":"80","author":"MS Ahadi","year":"2022","unstructured":"Ahadi MS, Fuchs TL, Clarkson A, Sheen A, Sioson L, Chou A, Gill AJ. Switch\/sucrose-non-fermentable (SWI\/SNF) complex (SMARCA4, SMARCA2, INI1\/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas. Histopathology. 2022;80:906\u201321.","journal-title":"Histopathology"},{"key":"4450_CR39","doi-asserted-by":"publisher","first-page":"762598","DOI":"10.3389\/fimmu.2021.762598","volume":"12","author":"L Peng","year":"2021","unstructured":"Peng L, Li J, Wu J, Xu B, Wang Z, Giamas G, Stebbing J, Yu Z. A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers. Front Immunol. 2021;12:762598.","journal-title":"Front Immunol"},{"key":"4450_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12672-023-00639-w","volume":"14","author":"J Jiang","year":"2023","unstructured":"Jiang J, Chen Z, Gong J, Han N, Lu H. Thoracic SMARCA4-deficient undifferentiated tumor. Discov Oncol. 2023;14:51.","journal-title":"Discov Oncol"},{"key":"4450_CR41","doi-asserted-by":"publisher","first-page":"175883592513990","DOI":"10.1177\/17588359251399031","volume":"17","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu ZH, Zhang Q, Bai YM, Guo XB, Ji HC, Zhang HM. Tumor-agnostic therapy: a potential therapeutic approach for SMARCA4-deficient malignancies. Ther Adv Med Oncol. 2025;17:17588359251399031.","journal-title":"Ther Adv Med Oncol"},{"key":"4450_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12967-025-07574-0","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Yan B, Yang J, Cheng Z, Song W, Yang Y, Wang J. Multi-omics integration and machine learning define robust molecular subtypes and prognostic signatures in hepatocellular carcinoma. J Transl Med. 2025;24:207.","journal-title":"J Transl Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04450-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04450-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04450-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:35Z","timestamp":1787242295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04450-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4450"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04450-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies involving humans were approved by the Ethics Committee of Guangxi Zhuang Autonomous Region People\u2019s Hospital. These patients gave written informed consent for the use of tissue specimens.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"342"}}